UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018926
Receipt number R000021896
Scientific Title Efficacy of minodronate and denosumab for bone loss in patients with prostate cancer undergoing androgen deprivation therapy
Date of disclosure of the study information 2015/09/14
Last modified on 2020/12/09 14:07:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of minodronate and denosumab for bone loss in patients with prostate cancer undergoing androgen deprivation therapy

Acronym

the PROMADE (prevention of osteopenia with minodronate and denosumab) study

Scientific Title

Efficacy of minodronate and denosumab for bone loss in patients with prostate cancer undergoing androgen deprivation therapy

Scientific Title:Acronym

the PROMADE (prevention of osteopenia with minodronate and denosumab) study

Region

Japan


Condition

Condition

Osteopenia

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy of minodronate and denosumab for bone loss in men with prostate cancer treated with androgen deprivation therapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

The percentage change in spine BMD

Key secondary outcomes

The percentage change in total hip and femoral neck
The percentage changes in bone markers of resorption and formation
The incidence of skeletal-related event
The incidence of adverse events in minodronate and denosumab treatment
The Adherence of minodronate and denosumab
The efficacy of each drug(the percentage change in BMD, The percentage changes in bone markers )


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

oral monthly minodronate,
50 mg once monthly, use for 1year

Interventions/Control_2

subcutaneous injection of
denosumab, 60 mg every 6 months
use for 1 year

Interventions/Control_3

observation (contorol) for 1 year

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1)ECOG performance status 0-1
2)Androgen deprivation therapy planned more than next one year
3) Androgen deprivation therapy<1 yr
,or Androgen deprivation therapy>1 yr and Young Adult Mean<90%

Key exclusion criteria

1)Bone metastasis
2)Castration resistance prostate cancer
3)hypocalcaemia Ca<8mg/dl
4)Androgen deprivation therapy>1 yr
and Young Adult Mean>90%
5)Prior treatment with a bisphosphonate, RANKL, parathyroid hormone
6)Prior treatment with a glucocorticoids
7)Under treatment of tooth
8)A history of achalasia
9)Estimated glomerular filtration rate <35 ml/min
10)Liver function tests>1.5 times the upper limit of normal
11)Bilateral hip replacement
12)A history of metabolic bone
disease (Paget disease, hyperparathyroidism, osteomalacia, untreated hypothyroidism)
13) The patients should be excluded
,Who have poor medical compliance, drug-induced allergy, etc.

Target sample size

99


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Yoshida

Organization

Kansai Medical University


Division name

Department of Urology and Andrology

Zip code

573-1191

Address

Shin-machi 2-5-1, Hirakata, Osaka 573-1010, Japan

TEL

072-804-2083

Email

yoshidtk@takii.kmu.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Yoshida

Organization

Kansai Medical University

Division name

Department of Urology and Andrology

Zip code

573-1191

Address

Shin-machi 2-5-1, Hirakata, Osaka 573-1010, Japan

TEL

072-804-2083

Homepage URL


Email

yoshidtk@takii.kmu.ac.jp


Sponsor or person

Institute

Department of Urology and Andrology, Kansai Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethic Committee of Kansai medical university

Address

2-3-1 Shin-Machi, Hirakata, 573-1191, Osaka, Japan

Tel

072-804-2083

Email

kenkyu@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西医科大学附属枚方病院(大阪府)


Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

102

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 09 Month 02 Day

Date of IRB

2015 Year 09 Month 14 Day

Anticipated trial start date

2015 Year 09 Month 24 Day

Last follow-up date

2019 Year 07 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 09 Month 07 Day

Last modified on

2020 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021896


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name